ISEC Healthcare (40T) Q1 2026 earnings summary

Executive summary

• Revenue rose 4% year-over-year to $18.62 million for the quarter ended 31 March 2026, driven by higher specialised and general health services revenue.

• Net profit declined 11% year-over-year to $2.75 million, mainly due to increased cost of sales and higher administrative expenses.

• Total comprehensive income increased 24% year-over-year to $3.41 million, aided by favorable foreign currency translation.

Financial highlights

• Specialised health services revenue increased by $0.67 million, supported by a stronger Malaysian Ringgit.

• Cost of sales rose 11% year-over-year, mainly from higher lens costs and revised doctor remuneration.

• Gross profit margin fell to 41.9% from 45.3% year-over-year due to increased costs.

• Administrative expenses rose by $0.15 million, primarily from higher staff costs.

• Other expenses dropped by $0.14 million, mainly from lower exchange losses.

Segment performance

• Specialised health services revenue reached $17.62 million, up from $16.95 million year-over-year.

• General health services revenue increased by $0.09 million, reflecting higher business activity and government vaccination programs.